Get a glimpse into our company and investor data—powered by the PitchBook Platform
Provider of bio-marker development services. The company operates as a early-stage molecular diagnostics company focused on providing cures for neurological diseases.
This information is reserved for PitchBook Platform users. To explore Narus Biotechnologies‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.